Inspiring the next breakthroughs in cancer therapy with Tikva Allocell's Dr. Ivan Horak

22:36 | Mar 28th

Dr. Ivan Horak is currently the CEO and founder of Tikva Allocell, a biotech company whose mission is to develop safe, effective, readily available and affordable “off-the-shelf” T cell therapies by l...Show More